What if AI doesn't actually engage in thought at all? An advanced AI model known as Centaur astonished researchers by matching human performance across 160 cognitive evaluations. However, a recent ...

In January middle school and high school students at more than 200 host sites across the U.S. and parts of Canada competed in the North American Computational Linguistics Open Competition (NACLO), ...

SALT LAKE CITY - Myriad Genetics, Inc. (NASDAQ:MYGN) announced today that the U.S. Food and Drug Administration has approved the MyChoice CDx Test as a companion diagnostic for Zejula (niraparib), a ...

SALT LAKE CITY, March 17, 2026 (GLOBE NEWSWIRE)-- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced that the U.S. Food and Drug ...

Rare diseases often remain undiagnosed for long periods, not because symptoms are absent, but because they may be subtle, overlapping, or easily misinterpreted in clinical settings. Early recognition ...

Lazio have two training sessions remaining before Sunday’s clash with Milan, and Maurizio Sarri still has several fitness questions to resolve before finalising his squad. The most significant concern ...

SINGAPORE: Singaporeans at high risk of hereditary breast and ovarian cancer (HBOC) will have access to subsidised genetic testing from December, the Ministry of Health (MOH) said on Thursday (Mar 5).

A Somali driver caught barreling an “80-ton truck” the wrong way down a Missouri highway failed an English proficiency test — and wasn’t able to read road signs, authorities said. The trucker was ...

Scientists in Newcastle, where the test was developed, hailed it as a "revolution" A pioneering test is improving early diagnosis for people with hereditary cancer caused by a genetic condition. Just ...

Further reviews and tests did not indicate any cancers common during pregnancies. Even though kidney cancer is rare in young women, Neas’ family history made Webster pause and conduct a CT scan. The ...

Milestone highlights growing adoption of DNA and RNA-informed diagnostics for hereditary cancer and rare disease Ambry Genetics first implemented RNA testing in 2016 as part of a research and ...